Response adaptive salvage with KTd and ASCT for functional high‐risk multiple myeloma—The Australasian Leukemia and Lymphoma Group (ALLG) MM17 Trial. - Turner, R.; Quach, H.; Horvath, N.; Kerridge, I.; Lee, E.; Morris, E.; Kalff, A.; Khong, T.; Reynolds, J.; Spencer, A. (British Journal of Haematology, 2023)